Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: Microbiological and echocardiographic analyses

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 7, 1999, Pages 1737-1742

  Xiong, Yan Qiong ^a,d   Kupferwasser, Leon Iri ^a   Zack, Philip M ^b   Bayer, Arnold S ^a,c  

^a St John's Cardiovascular Research Center   (United States)

^b GILEAD SCIENCES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; LIPOSOME; OXACILLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; FEMALE; HEART LEFT VENTRICLE FUNCTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ABSCESS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SPLEEN ABSCESS; STAPHYLOCOCCUS AUREUS; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0032772953     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.7.1737     Document Type: Article

References (33)

1. Bayer, A. S. 1982. Staphylococcal bacteremia and endocarditis. Arch. Intern. Med. 142:1169-1177.
2. 1a. Bayer, A. S. Unpublished data.
3. Caron, F., M. Pestel, M. D. Kitzis, J. F. Lemeland, G. Humbert, and L. Gutmann. 1995. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. J. Infect. Dis. 171:106-112.
4. Chambers, H. F., G. Archer, and M. Matsuhashi. 1989. Low-level methicillin resistance in strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 33:424-428.
5. Chambers, H. F., M. Sachdeva, and S. Kennedy. 1990. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of β-lactam antibiotics against methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 162:705-710.
6. Craig, W. A., and S. Gudmundson. 1991. Postantibiotic effect, p. 403-431. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., London, England.
7. Drugeon, H., F. Le Gallou, and J. Caillon. 1990. Methods d'etudes de l'activite bactericide, p. 112-126. In P. Courvalin, H. Drugeon, J. P. Flandrou, and F. Goldstein (ed.), Bactericidie: aspects theoriques et therapeutiques. Editions Maloine, Paris, France.
8. Eng, E., B. McAndrews, A. Satorius, R. T. Proffitt, and J. Adler-Moore. 1997. Comparative efficacy of amikacin and liposomal amikacin in the treatment of Klebsiella pneumoniae infection in mice, abstr. A-26. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C.
9. Espersen, F., and N. Frimodt-Moller. 1986. Staphylococcus aureus endocarditis: a review of 119 cases. Arch. Intern. Med. 146:1118-1121.
10. Fantin, B., and C. Carbon. 1992. In vivo antibiotic synergism: contribution of animal models. Antimicrob. Agents Chemother. 36:907-912.
11. Fielding, R. M., R. O. Lewis, and L. Moon-McDermott. 1998. Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome). Pharmacol. Res. 15:1775-1781.
12. Fielding, R. M., G. Mukwaya, and R. A. Sandhaus. 1998. Clinical and preclinical studies with low-clearance liposomal amikacin (MiKasome), p. 213-225. In M. C. Woodle and G. Storm (ed.), Long-circulating liposomes: old drugs, new therapeutics. Springer-Verlag, New York, N.Y.
13. Fierer, J., L. Hatlen, J.-P. Lin, D. Estrella, P. Mihalko, and A. Yau-Young. 1990. Successful treatment using gentamicin liposomes of Salmonella dublin infections in mice. Antimicrob. Agents Chemother. 34:343-348.
14. Fountain, M. W., S. K. Weiss, A. G. Fountain, A. Shen, 61nd R. P. Lenk. 1985. Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycoside. J. Infect. Dis. 152:529-535.
15. Ginsberg, R. S., G. M. Mitilenes, R. P. Lenk, J. A. Jedrusiak, K. Savage, and C. E. Swenson. 1988. The impact of liposome encapsulation of gentamicin on the treatment of extracellular Gram-negative bacterial infections. UCLA Symp. Mol. Cell Biol. New Ser. 89:205-214.
16. Hirano, L., and A. S. Bayer. 1991. β-Lactam-β-laclamase inhibitor combinations are active in experimental endocarditis caused by β-lactamase-producing oxacillin-resistant staphylococci. Antimicrob. Agents Chemother. 35: 685-690.
17. Hoit, B. D., S. F. Khoury, E. G. Kranias, N. Ball, and R. A. Walsh. 1995. In vitro echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ. Res. 77:632-637.
18. Karlowsky, J. A., and G. G. Zhanel. 1992. Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides. Clin. Infect. Dis. 15: 654-667.
19. Kupferwasser, L. I., H. Darius, M. Buerke, H. J. Rupprecht, S. Mohr-Kahaly, and J. Meyer. 1998. Transesophageal ultrasonographic imaging in rat heart. Visualization of aortic valve vegetations in non-bacterial thrombotic endocarditis. J. Am. Soc. Echocardiogr. 11:201-205.
20. Lewis, R. P., and H. Sandler. 1971. Relationship between changes in left ventricular dimension and the ejection fraction in man. Circulation 44:548-557.
21. Lopez-Berestein, G. 1987. Liposomes as carriers of antimicrobial agents. Antimicrob. Agents Chemother. 31:675-678.
22. Meyer, R. D., and S. Liu. 1988. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa. Diagn. Microbiol. Infect. Dis. 11:151-157.
23. Moellering, R. C., C. Wennersten, and A. N. Weinberg. 1971. Studies on antibiotic synergism against enterococci. 1. Bacteriologic studies. J. Lab. Clin. Med. 77:821-828.
24. Morgan, J. R., and W. E. Williams. 1980. Preparation and properties of liposome-associated gentamicin. Antimicrob. Agents Chemother. 17:544-548.
25. Perlman, B. B., and L. S. Freedman. 1971. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J. Biol. Med. 42:394-410.
26. Picard, M. H. 1994. M-mode echocardiography: principles and examination techniques, p. 282-301. In A. E. Weyman (ed.), Principles and practice of echocardiography, 2nd ed. Lea & Febiger, New York, N.Y.
27. Pollick, C., S. L. Hale, and R. A. Kloner. 1995. Echocardiographic and cardiac assessment of mice. J. Am. Soc. Echocardiogr. 8:602-610.
28. Sahn, D. J., A. N. DeMaria, J. Kisslo, and A. E. Weyman. 1978. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083.
29. Swenson, C. E., K. A. Stewart, J. L. Hammett, W. E. Fitzsimmons, and R. S. Ginsberg. 1990. Pharmacokinetics and in vivo activity of liposome-encapsulated gentamicin. Antimicrob. Agents Chemother. 34:235-240.
30. Tunkel, A. R., and G. L. Mandell. 1992. Infecting microorganisms, p. 85-97. In D. Kaye (ed.), Infective endocarditis, 2nd ed. Raven Press, Ltd., New York, N.Y.
31. Wainai, Y. 1991. Adaptive mechanisms of the aorta and the left ventricle to volume overloading following abrupt aortic regurgitation in rabbits. Cardiovasc. Res. 25:463-467.
32. Xiong, Y. Q., J. Adler-Moore, P. Zack, and A. S. Bayer. 1997. Efficacy of MiKasome (a liposomal amikacin formulation) versus free amikacin in experimental endocarditis due to Pseudomonas aeruginosa, abstr. A-30. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C.
33. Zack, P. M., S. M. Zondler, A. Magallanez, Y. Q. Xiong, J. P. Adler-Moore, and A. S. Bayer. 1997. Treatment with liposomal amikacin reduces myocarditis in the rabbit model of Pseudomonas aeruginosa endocarditis, abstr. B-30a. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.